Sensorion Completes Second Cohort Enrollment in OTOF Gene Therapy Clinical Trial
SENS-501 is a gene therapy candidate being developed to treat a form of congenital deafness linked to mutations in the OTOF (otoferlin) gene.
Tag: pharmaceuticals
All
Latest
All
Latest
New Technology Could Help Treat Hearing Loss More Effectively
A researcher received funding from the NIH to research the use of magnetic nanoparticles for drug delivery for hearing loss treatment.
All
Latest
Frequency Therapeutics Updates Progress on Hearing Loss Treatments, Q1 2021 Financials
In the company’s announcement, Frequency Therapeutics provides updates on data from its recent FX-322 Clinical Readouts, including new information from a Phase 1b study in presbycusis, and further clarifies acquired sensorineural hearing loss target populations and future study design. The company anticipates initiating a new FX-322 Phase 2 Study in H2 2021.
